Press "Enter" to skip to content

Drug companies avert landmark opioids trial as talks on $48 billion settlement set to resume

Four large drug companies could resume talks on Tuesday to try to reach a $48 billion settlement of all opioid litigation against them, after agreeing with two Ohio counties to a $260 million deal to avert the first federal trial over their role in the U.S. opioid epidemic.

Source:: Breaking News

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *